Sunflower Pharmaceutical Group Co.,Ltd (SHE: 002737)

Sunflower Pharmaceutical Group Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,705	2,287	2,399	1,320	1,648	1,466
Short-Term Investments	-	-	-	304.42	-	-
Trading Asset Securities	800	1,315	1,449	668.69	150.49	205
Cash & Short-Term Investments	2,505	3,602	3,847	2,293	1,798	1,671
Cash Growth	-21.02%	-6.38%	67.77%	27.52%	7.63%	13.48%
Accounts Receivable	611.11	110.13	184.25	268.98	286.85	663.36
Other Receivables	43.21	41.42	42.57	12.21	24.16	16.22
Receivables	654.32	151.56	226.82	281.19	311.02	679.58
Inventory	907.06	873.19	632.08	709.64	562.17	664.55
Prepaid Expenses	49.85	44.3	3.74	8.75	-	4.28
Other Current Assets	113.09	116.81	151.03	100.11	265.69	73.64
Total Current Assets	4,229	4,788	4,861	3,393	2,937	3,093
Property, Plant & Equipment	1,387	1,435	1,497	1,577	1,609	1,520
Long-Term Investments	107.72	122.44	141.38	131.32	3.09	3.2
Goodwill	91.77	91.77	91.77	107.6	134.82	171.55
Other Intangible Assets	341.95	345.37	366.52	337.77	350.8	384.54
Long-Term Deferred Tax Assets	49.41	58.92	56.51	55.78	59.5	76.68
Long-Term Deferred Charges	7.9	8.86	6.81	1.87	3.76	5.4
Other Long-Term Assets	36.02	31.39	10.85	30.77	15.31	54.85
Total Assets	6,251	6,882	7,032	5,635	5,113	5,309
Accounts Payable	814.25	734.6	714.48	547.18	447.88	528.97
Accrued Expenses	190.97	259.07	301.01	124.75	111.67	115.54
Short-Term Debt	-	14.43	420	200	240.52	300
Current Portion of Leases	3.25	4.46	5.59	3.5	-	-
Current Income Taxes Payable	67.67	87.53	60.21	43.54	70.36	60.64
Current Unearned Revenue	33.88	297.32	551.54	167.04	121.21	102.42
Other Current Liabilities	180.14	122.5	122.54	166.6	166.4	209.29
Total Current Liabilities	1,290	1,520	2,175	1,253	1,158	1,317
Long-Term Debt	-	-	-	33.57	70.01	126.45
Long-Term Leases	8.27	7.62	10.5	7.01	-	-
Long-Term Unearned Revenue	337.69	342.08	397.26	389.08	380.37	414.49
Long-Term Deferred Tax Liabilities	6.6	7.61	9.89	17.82	20.23	21.84
Other Long-Term Liabilities	-	-	-	-	93.93	-
Total Liabilities	1,643	1,877	2,593	1,700	1,723	1,880
Common Stock	584	584	584	584	584	584
Additional Paid-In Capital	920.83	915.66	889.99	896.7	930	889.92
Retained Earnings	2,862	3,252	2,716	2,256	1,753	1,751
Treasury Stock	-	-	-	-44	-106.33	-22.76
Comprensive Income & Other	11.18	12.28	14.38	16.77	19.47	21.9
Total Common Equity	4,378	4,763	4,205	3,709	3,180	3,224
Minority Interest	230.39	241.25	234	225.72	210.53	205.53
Shareholders' Equity	4,608	5,005	4,439	3,935	3,391	3,430
Total Liabilities & Equity	6,251	6,882	7,032	5,635	5,113	5,309
Total Debt	11.51	26.52	436.08	244.08	310.53	426.45
Net Cash (Debt)	2,493	3,576	3,411	2,049	1,488	1,244
Net Cash Growth	-19.97%	4.82%	66.47%	37.72%	19.56%	-2.45%
Net Cash Per Share	4.26	6.13	5.82	3.52	2.55	2.13
Filing Date Shares Outstanding	584	584	584	587.54	576.87	582.42
Total Common Shares Outstanding	584	584	584	587.54	576.87	582.42
Working Capital	2,939	3,268	2,686	2,140	1,779	1,776
Book Value Per Share	7.50	8.16	7.20	6.31	5.51	5.54
Tangible Book Value	3,944	4,326	3,746	3,264	2,695	2,668
Tangible Book Value Per Share	6.75	7.41	6.42	5.56	4.67	4.58
Buildings	1,612	1,612	1,604	1,589	1,389	1,189
Machinery	1,094	1,075	1,014	982.56	906.81	847.3
Construction In Progress	42	35.7	30.29	19.15	216.6	321.72

Source: S&P Capital IQ. Standard template. Financial Sources.